FindTrial
Sign In

How safe & effective is Endovenous Laser Ablation (EVLA) of lower limb varicose vein in Patients with both Superficial and Deep Venous Disease.

The Safety & Efficacy of Endovenous Laser Ablation of Superficial Vein in Patients with Combined Superficial and Segmental Deep Venous Disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054329
Enrollment
35
Registered
2023-06-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I83- Varicose veins of lower extremities

Interventions

Intervention1: Emdovenous laser Ablation (EVLA) of Superficial veins of lower limbs: Duration of each EVLA procedure is around 1-2 hours. Duration trial will be 18 months Control Intervention1: not ap

Sponsors

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, JODHPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with varicose veins with both superficial & deep venous reflux patient with >70% recanalized chronic deep venous thrombosis with superficial reflux patients with post-thrombotic varicose veins with superficial reflux will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Patient with acute DVT. 2. Pregnancy. 3. Patients on chronic hemodialysis. 4. Non-consenting patients.

Design outcomes

Primary

MeasureTime frame
safety & efficacy of endovenous laser ablation of superficial veins in patients with combined superficial and segmental deep venous diseaseTimepoint: POST OPERATIVE DAY 1, 1 MONTH & 3 MONTH—

Secondary

MeasureTime frame
rate of technical success, the incidence of recurrent DVT post procedure, other complications, and recurrence of varicose veins.Timepoint: POST OPERATIVE DAY 1, 1 MONTH & 3 MONTHS.—

Countries

India

Contacts

Public ContactRajjat Shaikh

All India Institute of Medical Sciences

pushpinderkhera@gmail.com8003996914

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026